BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.26B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$969M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$963M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$946M |
| 5 |
Microsoft
MSFT
|
+$803M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$219M |
| 2 |
Tesla
TSLA
|
+$156M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$147M |
| 4 |
American Tower
AMT
|
+$134M |
| 5 |
Uber
UBER
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.18% |
| 2 | Financials | 8.26% |
| 3 | Consumer Discretionary | 5.82% |
| 4 | Healthcare | 4.57% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Cytosorbents Corp
CTSO
$23.5M
| $46.1K | ﹤0.01% |
5,314
-2,066
| -28% | -$19.7K |
|
|
SYRS
3502
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $46K | ﹤0.01% |
616
-290
| -32% | -$30.1K |
|
3503
NLI Holdings
NL
$324M
| $46K | ﹤0.01% |
6,169
+1,865
| +43% | +$10.5K |
|
3504
RGC Resources
RGCO
$226M
| $45.7K | ﹤0.01% |
2,061
+824
| +67% | +$19.3K |
|
3505
Assembly Biosciences
ASMB
$589M
| $45.6K | ﹤0.01% |
827
+164
| +25% | +$10.9K |
|
3506
PUT
Archer Daniels Midland
ADM
$38.8B
| $45.6K | ﹤0.01% |
8
-334
| -98% | -$18.3K |
|
|
CBIO
3507
Crescent Biopharma
CBIO
$621M
| $45.4K | ﹤0.01% |
151
+80
| +113% | +$28.7K |
|
3508
Cue Biopharma
CUE
$130M
| $45.2K | ﹤0.01% |
124
+7
| +6% | +$2.88K |
|
|
VXRT
3509
DELISTED
Vaxart
VXRT
| $44.7K | ﹤0.01% |
7,383
+1,805
| +32% | +$13.9K |
|
|
PAMT
3510
PAMT Corp
PAMT
$282M
| $44.2K | ﹤0.01% |
2,868
+1,372
| +92% | +$19.7K |
|
|
AC
3511
DELISTED
Associated Capital Group
AC
| $44.2K | ﹤0.01% |
1,233
+889
| +258% | +$31.5K |
|
3512
Clearfield
CLFD
$396M
| $44.2K | ﹤0.01% |
1,467
-712
| -33% | -$22.6K |
|
|
MTEM
3513
DELISTED
Molecular Templates, Inc.
MTEM
| $44.2K | ﹤0.01% |
233
-100
| -30% | -$17.5K |
|
|
CIZN
3514
DELISTED
Citizens Holding Co.
CIZN
| $44K | ﹤0.01% |
2,213
+1,202
| +119% | +$24.6K |
|
3515
Ooma
OOMA
$564M
| $43.2K | ﹤0.01% |
2,727
-843
| -24% | -$13.1K |
|
3516
Universal Technical Institute
UTI
$1.44B
| $42.5K | ﹤0.01% |
7,284
-1,220
| -14% | -$7.53K |
|
|
SBT
3517
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $42.3K | ﹤0.01% |
7,468
+2,302
| +45% | +$12K |
|
3518
Auburn National Bancorp
AUBN
$91.1M
| $42.1K | ﹤0.01% |
1,098
+553
| +101% | +$22.6K |
|
3519
INNOVATE Corp
VATE
$103M
| $41.9K | ﹤0.01% |
1,064
-484
| -31% | -$18K |
|
|
APTX
3520
DELISTED
Aptinyx Inc. Common Stock
APTX
| $41.7K | ﹤0.01% |
13,915
+7,896
| +131% | +$28.4K |
|
|
LUNA
3521
DELISTED
Luna Innovations Incorporated
LUNA
| $41.7K | ﹤0.01% |
3,957
-1,947
| -33% | -$21.8K |
|
3522
Q32 Bio
QTTB
$468M
| $41.4K | ﹤0.01% |
245
-112
| -31% | -$23.6K |
|
3523
Savara
SVRA
$1.11B
| $40.8K | ﹤0.01% |
19,636
+11,306
| +136% | +$19.3K |
|
3524
Vitamin Cottage Natural Grocers
NGVC
$648M
| $40.6K | ﹤0.01% |
2,315
+481
| +26% | +$7.6K |
|
|
CORR
3525
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $40.6K | ﹤0.01% |
5,744
+2,613
| +83% | +$20.9K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2021 Portfolio in Review
As of Q1 2021, BNP Paribas Financial Markets held 4,269 positions worth $68.3B, up 27% from $53.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets deployed $15.9B of net new capital in Q1 2021, opening 125 new positions and adding to 2,252 existing holdings. Its largest new stake was State Street SPDR S&P Homebuilders ETF: 612,151 shares worth $43.1M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.2% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Home Depot, an estimated $219M trimmed.
- BNP Paribas Financial Markets's largest Q1 2021 buy was State Street SPDR S&P Homebuilders ETF: 612,151 shares worth $43.1M.
- BNP Paribas Financial Markets added most to Apple in Q1 2021, an estimated $1.26B increase.
- BNP Paribas Financial Markets's biggest Q1 2021 reduction was Home Depot, cutting an estimated $219M.
- BNP Paribas Financial Markets fully exited Lumen in Q1 2021, selling an estimated $9.65M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $68.3B portfolio in Q1 2021.
- BNP Paribas Financial Markets opened 125 new positions and closed 272 in Q1 2021.
- BNP Paribas Financial Markets's portfolio value rose 27% quarter-over-quarter to $68.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.